Literature DB >> 20613750

VEGF and ephrin-B2: a bloody duo.

Stéphane Germain, Anne Eichmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20613750     DOI： 10.1038/nm0710-752

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  Bidirectional Eph-ephrin signaling during axon guidance.

Authors:  Joaquim Egea; Rüdiger Klein
Journal:  Trends Cell Biol       Date:  2007-04-08       Impact factor: 20.808

2.  Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.

Authors:  Yingdi Wang; Masanori Nakayama; Mara E Pitulescu; Tim S Schmidt; Magdalena L Bochenek; Akira Sakakibara; Susanne Adams; Alice Davy; Urban Deutsch; Urs Lüthi; Alcide Barberis; Laura E Benjamin; Taija Mäkinen; Catherine D Nobes; Ralf H Adams
Journal:  Nature       Date:  2010-05-27       Impact factor: 49.962

3.  Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.

Authors:  Suphansa Sawamiphak; Sascha Seidel; Clara L Essmann; George A Wilkinson; Mara E Pitulescu; Till Acker; Amparo Acker-Palmer
Journal:  Nature       Date:  2010-05-05       Impact factor: 49.962

4.  VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis.

Authors:  Anthony A Lanahan; Karlien Hermans; Filip Claes; Joanna S Kerley-Hamilton; Zhen W Zhuang; Frank J Giordano; Peter Carmeliet; Michael Simons
Journal:  Dev Cell       Date:  2010-05-06       Impact factor: 12.270

5.  Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.

Authors:  S S Gerety; H U Wang; Z F Chen; D J Anderson
Journal:  Mol Cell       Date:  1999-09       Impact factor: 17.970

6.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.

Authors:  R H Adams; G A Wilkinson; C Weiss; F Diella; N W Gale; U Deutsch; W Risau; R Klein
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

7.  Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.

Authors:  Tuomas Tammela; Georgia Zarkada; Elisabet Wallgard; Aino Murtomäki; Steven Suchting; Maria Wirzenius; Marika Waltari; Mats Hellström; Tibor Schomber; Reetta Peltonen; Catarina Freitas; Antonio Duarte; Helena Isoniemi; Pirjo Laakkonen; Gerhard Christofori; Seppo Ylä-Herttuala; Masabumi Shibuya; Bronislaw Pytowski; Anne Eichmann; Christer Betsholtz; Kari Alitalo
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

8.  Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation.

Authors:  Shane P Herbert; Jan Huisken; Tyson N Kim; Morri E Feldman; Benjamin T Houseman; Rong A Wang; Kevan M Shokat; Didier Y R Stainier
Journal:  Science       Date:  2009-10-09       Impact factor: 47.728

9.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

10.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.

Authors:  Holger Gerhardt; Matthew Golding; Marcus Fruttiger; Christiana Ruhrberg; Andrea Lundkvist; Alexandra Abramsson; Michael Jeltsch; Christopher Mitchell; Kari Alitalo; David Shima; Christer Betsholtz
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539
View more
  12 in total

1.  Multivalent biomaterial platform to control the distinct arterial venous differentiation of pluripotent stem cells.

Authors:  Taylor B Dorsey; Diana Kim; Alexander Grath; Daylon James; Guohao Dai
Journal:  Biomaterials       Date:  2018-09-03       Impact factor: 12.479

2.  Expression of dual angiogenic/neurogenic growth factors in human primary brain tumors.

Authors:  Maud Clemessy; Robert C Janzer; Benoìt Lhermitte; Jean-Marie Gasc; Lucienne Juillerat-Jeanneret
Journal:  J Neurooncol       Date:  2011-10-07       Impact factor: 4.130

3.  Novel strategy for selection of monoclonal antibodies against highly conserved antigens: phage library panning against ephrin-B2 displayed on yeast.

Authors:  Xiaoling Gu; Yogindra Vedvyas; Xiaoyue Chen; Tanwi Kaushik; Chang-Il Hwang; Xuebo Hu; Alexander Y Nikitin; Moonsoo M Jin
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

4.  Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusion.

Authors:  Shin-Young Park; Alessandro Matte; Yookyung Jung; Jina Ryu; Wilson Babu Anand; Eun-Young Han; Min Liu; Carmine Carbone; Davide Melisi; Takashi Nagasawa; Joseph J Locascio; Charles P Lin; Leslie E Silberstein; Lucia De Franceschi
Journal:  Blood       Date:  2020-06-04       Impact factor: 25.476

5.  Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells.

Authors:  Li-Chun Zheng; Xiao-Qing Wang; Kun Lu; Xiao-Ling Deng; Cheng-Wei Zhang; Hong Luo; Xu-Dong Xu; Xiao-Man Chen; Lu Yan; Yi-Qing Wang; Song-Lin Shi
Journal:  Oncotarget       Date:  2017-06-20

6.  Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments.

Authors:  Christin Neuber; Birgit Belter; Sebastian Meister; Frank Hofheinz; Ralf Bergmann; Hans-Jürgen Pietzsch; Jens Pietzsch
Journal:  Molecules       Date:  2018-02-17       Impact factor: 4.411

7.  HMQ-T-B10 induces human liver cell apoptosis by competitively targeting EphrinB2 and regulating its pathway.

Authors:  Bingling Dai; Xianpeng Shi; Nan Ma; Weina Ma; Yanmin Zhang; Tianfeng Yang; Jie Zhang; Langchong He
Journal:  J Cell Mol Med       Date:  2018-09-14       Impact factor: 5.310

Review 8.  The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.

Authors:  Enming Du; Xue Li; Siyu He; Xiaohua Li; Shikun He
Journal:  Mol Biol Rep       Date:  2020-06-02       Impact factor: 2.316

9.  The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis.

Authors:  Anthony Lanahan; Xi Zhang; Alessandro Fantin; Zhen Zhuang; Felix Rivera-Molina; Katherine Speichinger; Claudia Prahst; Jiasheng Zhang; Yingdi Wang; George Davis; Derek Toomre; Christiana Ruhrberg; Michael Simons
Journal:  Dev Cell       Date:  2013-04-29       Impact factor: 12.270

10.  Inhibition of Ephrin B3-mediated survival signaling contributes to increased cell death response of non-small cell lung carcinoma cells after combined treatment with ionizing radiation and PKC 412.

Authors:  S Ståhl; V O Kaminskyy; G Efazat; A Hyrslova Vaculova; S Rodriguez-Nieto; A Moshfegh; R Lewensohn; K Viktorsson; B Zhivotovsky
Journal:  Cell Death Dis       Date:  2013-01-10       Impact factor: 8.469
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.